- Home
- OCCI vs ASRT Comparison
OCCI vs ASRT Comparison
Compare OCCI & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCCI
- ASRT
- Stock Information
- Founded
- OCCI N/A
- ASRT 1995
- Country
- OCCI United States
- ASRT United States
- Employees
- OCCI N/A
- ASRT N/A
- Industry
- OCCI Trusts Except Educational Religious and Charitable
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- OCCI Finance
- ASRT Health Care
- Exchange
- OCCI Nasdaq
- ASRT Nasdaq
- Market Cap
- OCCI 160.5M
- ASRT 57.9M
- IPO Year
- OCCI N/A
- ASRT 1997
- Fundamental
- Price
- OCCI $6.28
- ASRT $0.70
- Analyst Decision
- OCCI
- ASRT Strong Buy
- Analyst Count
- OCCI 0
- ASRT 2
- Target Price
- OCCI N/A
- ASRT $3.25
- AVG Volume (30 Days)
- OCCI 115.8K
- ASRT 243.1K
- Earning Date
- OCCI 12-11-2023
- ASRT 08-06-2025
- Dividend Yield
- OCCI 24.32%
- ASRT N/A
- EPS Growth
- OCCI N/A
- ASRT N/A
- EPS
- OCCI N/A
- ASRT N/A
- Revenue
- OCCI N/A
- ASRT $119,001,000.00
- Revenue This Year
- OCCI N/A
- ASRT N/A
- Revenue Next Year
- OCCI $10.19
- ASRT $11.91
- P/E Ratio
- OCCI N/A
- ASRT N/A
- Revenue Growth
- OCCI N/A
- ASRT N/A
- 52 Week Low
- OCCI $5.47
- ASRT $0.51
- 52 Week High
- OCCI $10.15
- ASRT $1.80
- Technical
- Relative Strength Index (RSI)
- OCCI 53.64
- ASRT 56.97
- Support Level
- OCCI $5.88
- ASRT $0.63
- Resistance Level
- OCCI $6.30
- ASRT $0.70
- Average True Range (ATR)
- OCCI 0.09
- ASRT 0.03
- MACD
- OCCI 0.03
- ASRT 0.00
- Stochastic Oscillator
- OCCI 83.33
- ASRT 77.89
About OCCI OFS Credit Company Inc.
OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation primarily through investment in collateralized loan obligation (CLO) equity and debt securities. The company invests in floating rate credit instruments and other structured credit investments, including; collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.